A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...
Whether reeling from a sudden stroke or buckling under the sustained assault of Alzheimer's, the brain becomes inflamed, ...
Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback